Search Results 341-350 of 12446 for alp

  1. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

    Stable liver tests, defined as ALT and either alkaline phosphatase or GGT either within normal limits OR ≤ 1.5 X baseline; No detectible circulating EBV or ...

  2. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer - Mayo Clinic

    - Alkaline phosphatase <3 × ULN - The etiology of abnormal bilirubin and transaminase levels should be evaluated prior to study entry. - Willingness to ...

  3. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer - Mayo Clinic

    Alkaline phosphatase ≤ 1.5 x institutional upper limit of normal (ULN);; AST/SGOT ≤ 2 x institutional upper limit of normal (ULN);; ALT/SGPT ≤ 2 x ...

  4. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

    ... alkaline phosphatase meet the protocol-specified levels for eligibility);; Alkaline phosphatase > 2.5 x ULN;; Glomerular filtration rate < 50 mL/min, as ...

  5. Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) - Mayo Clinic

    Chronically impaired renal function as expressed by creatinine clearance < 60 mL/min. Inadequate liver function (ALT, AST, ALP or total bilirubin ≥ 2.5 x ULN) ...

  6. Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris - Mayo Clinic

    ALT or AST > 2 x upper limits of normal (ULN); alkaline phosphatase (ALP) ≥ 2 x ULN; total bilirubin ≥ 1.5 x ULN; hemoglobin < 10 g/dL (100.0 g/L); total ...

  7. https://www.mayoclinic.org/chinese_organization_concepts.xml

  8. A Study of LY3154207 in Participants With Parkinson's Disease Dementia or Dementia with Lewy Bodies - Mayo Clinic

    ... alkaline phosphatase (ALP) equal to or higher than 2X ULN. Participants have answered 'yes' to either Question 4 (Active Suicidal Ideation with Some Intent ...

  9. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

    ALP ≤ 2.5 x ULN (≤ 5 x ULN in case of bone metastasis, biliary tract involvement or liver metastases). Adequate chemistry laboratory assessments, as ...

  10. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    Participation eligibility · Aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase < 3 x upper limit of normal (ULN); · Total bilirubin < ...